Assessment of Early Radiation Oncology Involvement Alongside Standard Oncologic Care in the Managemet

PHASE3RecruitingINTERVENTIONAL
Enrollment

156

Participants

Timeline

Start Date

July 13, 2023

Primary Completion Date

December 16, 2025

Study Completion Date

December 16, 2025

Conditions
Radiation TherapyMetastatic Cancer
Interventions
OTHER

Questionnaires

"All patients in Arm 2 will be seen and treated by one of three ROs with an interest in participating in this study, who will be trained by the PI to perform these visits reproducibly and with rigor. These will all be regular ROs, who like most ROs administer a mix of curative and PRT in their clinical practice; like most cancer centers, there are no ROs who formally subspecialize in PRT at our institution. Notably, patients in Arm 1 (control arm) will always have standard-of-care RO referral available for consideration of PRT if needed for symptom relief. However, patients in Arm 1 will be seen by other ROs without any specific training for this study. Any courses of PRT administered in either arm are at the discretion of the treating RO in terms of the timing, dose, fractionation, and treatment technique."

COMBINATION_PRODUCT

Early Radiation Oncology Involvement Alongside Standard Oncologic Care

Early Radiation Oncology Involvement Alongside Standard Oncologic Care

Trial Locations (6)

07302

RECRUITING

RWJBarnabas Health Jersey City Medical Center, Jersey City

08903

RECRUITING

Rutgers Cancer Institute of New Jersey, New Brunswick

RECRUITING

RWJBarnabas Health - Robert Wood Johnson University Hospital, New Brunswick

07103

RECRUITING

Malcolm David Mattes, MD, Newark

07112

RECRUITING

RWJBarnabas Health - Newark Beth Israel Medical Center, Newark

08873

RECRUITING

RWJBarnabas Health - Robert Wood Johnson University Hospital, Somerset

All Listed Sponsors
lead

Rutgers, The State University of New Jersey

OTHER